Powder: -20°C for 3 years | In solvent: -80°C for 1 year
C18 3'-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids. Levels of short-chain sulfatides, including C18 3'-sulfo galactosylceramide, decrease with age in mice and humans. It is increased in brain from mice with an arylsulfatase A deficiency (ASA-KO), particularly in lipid raft fractions. Plasma levels of C18 3'-sulfo galactosylceramide positively correlate with disability progression in patients with relapsing-remitting multiple sclerosis using the Expanded Disability Status Scale. It is also increased in plasma from patients with metachromatic leukodystrophy (MLD).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | $ 1,850.00 |
Description | C18 3'-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids. Levels of short-chain sulfatides, including C18 3'-sulfo galactosylceramide, decrease with age in mice and humans. It is increased in brain from mice with an arylsulfatase A deficiency (ASA-KO), particularly in lipid raft fractions. Plasma levels of C18 3'-sulfo galactosylceramide positively correlate with disability progression in patients with relapsing-remitting multiple sclerosis using the Expanded Disability Status Scale. It is also increased in plasma from patients with metachromatic leukodystrophy (MLD). |
Synonyms | C18 3'-sulfo Galactosylceramide (d18:1/18:0) |
Molecular Weight | 808.17 |
Formula | C42H81NO11S |
CAS No. | 244215-65-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Chloroform:Methanol (5:1): Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
C18 3'-sulfo Galactosylceramide (d18:1/18:0) 244215-65-4 C-18 3'-sulfo Galactosylceramide (d18:1/18:0) C18 3'sulfo Galactosylceramide (d18:1/18:0) C18 3'-sulfo Galactosylceramide C18 3' sulfo Galactosylceramide (d18:1/18:0) d18:1/18:0 inhibitor inhibit